Nkowa
A na-akpọkwa etiti ọdụ todacitibib anyị dị ka cis-1-benzyl-3-methylinoppiperiidiipine dihydylanopine dihydrochloride ma nwee ọnụọgụ 10625808080-52-2580-52-2580-52-258080-52-25-52-2580-52-2580-52-2. Ihe mgbochi bụ ihe dị mkpa na mmepụta nke tofacitinib, ọgwụ a na-eji agwọ ọrịa ogbu na nkwonkwo, ọrịa ogbu na nkwonkwo na ọnya afọ. Dịka etiti etiti na njikọta nke Tofacitinib, ngwaahịa anyị dị mkpa maka ndị na-eme ọgwụ na ndị na-emepụta ọgwụ.
A na-eji nlezianya na-eji nlezianya na-eji nlezianya na-eme ka ọ hụ na ọ dị oke egwu na ịdị ọcha. Site na usoro nrụpụta nke steeti na usoro njikwa dị mma, ị nwere ike ịtụkwasị obi na tofacitinib anyị na-ezute ụkpụrụ ụlọ ọrụ kachasị elu maka ịdị ọcha.
Tofacitinib etiti (3r, 4r) -1-benzyl-3- (mmthylano) -4-mmethyliperidine dihcliperidine (4-mmethylpiperidine dihclideridine nwere otutu ngwa, na-enye ya ezigbo uru na nyocha ọgwụ na nyocha ọgwụ. Ma ị na-eduzi nyocha agụmakwụkwọ ma ọ bụ na-ewulite ọgwụ, ihe anyị na-abanye na-enye azịza ndị a pụrụ ịdabere na mkpa gị.
Họrọ anyị
JDK nwere ihe owuwu mmepụta nke klaasị na usoro njikwa dị mma, nke na-emesi ihe ike na-abawanye nke Api etiti. Onye ọkachamara na-emesi ike na R & D nke ngwaahịa ahụ. Megide ha abụọ, anyị na-achọ CMO & Cdmo na ahịa ụlọ na nke mba ụwa.